The technology that gave the world mRNA COVID vaccines is being tested in a variety of new ways, and emerging research ...
The study also reviews the great potential of mRNA vaccines to treat influenza, RSV, cancer, and autoimmune diseases.
The Horizon programme contains a variety of mRNA assets in varying stages of development, including a preclinical in vivo ...
A review of data covering billions of doses of mRNA vaccines has found "compelling" evidence that the technology is both safe ...
Zacks Investment Research on MSN
MRNA stock on the move: What sparked the 33.5% jump in the past week?
Shares of Moderna MRNA have surged 33.5% over the past week, adding nearly $8 billion to the company's market value. The ...
Learn how mRNA vaccines work, why serious risks remain rare, and how the technology could be used beyond COVID-19. Many people who received an mRNA COVID-19 vaccine had no idea what mRNA was. Some ...
A research group used a unique 'PureCap' method to produce high purity mRNA vaccines with improved synthesis of proteins that stimulate the immune system and low inflammatory side effects. A research ...
On Sept. 4, 2025, Health and Human Services Secretary Robert F. Kennedy Jr. is scheduled to testify before the Senate Finance Committee, where he is expected to face questions about his vaccine ...
Robert F. Kennedy Jr., speaks after being sworn in as health and human services secretary in the Oval Office at the White House, Thursday, Feb. 13, 2025. [AP Photo/Alex Brandon] In the past few weeks, ...
Moderna (MRNA) climbed to $81.42, up 169% annually. Analysts set average target at $37 while insiders sold $6.1M worth of ...
Provides broad overview of Company's research and early development programs expected to continue to fuel future ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results